Lukaszewicz Bushen Jennifer, Mehta Jimish M, Hamilton Keith W, Timko Daniel R, Lautenbach Ebbing, Pegues David A
1Department of Pharmacy,Hospital of the University of Pennsylvania,Philadelphia,Pennsylvania.
2Teqqa,LLC.
Infect Control Hosp Epidemiol. 2017 Jan;38(1):89-95. doi: 10.1017/ice.2016.243. Epub 2016 Nov 9.
OBJECTIVE To assess the likelihood of antimicrobial streamlining between 2 antimicrobial stewardship methods. DESIGN Retrospective cohort study. SETTING Large academic medical center. METHODS Frequency and time to antimicrobial streamlining were compared during a prior authorization and a prospective audit period. Streamlining was defined as an antimicrobial change to a narrower agent if available or to a broader agent if the isolate was resistant to empiric therapy. Patients included were ≥18 years old with monomicrobial bacteremia with S. aureus, Enterococcus spp., or any aerobic Gram-negative organism. RESULTS A total of 665 cases of bacteremia met inclusion criteria. Frequency of streamlining was similar between periods for all cases of bacteremia (audit vs restriction: 60.7% vs 53.2%; P=.12), S. aureus bacteremia (73.2% vs 76.9%; P=.671), and Enterococcus bacteremia (81.6% vs 71.9%; P=.335). Compared to restriction, the audit period was associated with an increased frequency of streamlining for cases of Gram-negative bacteremia (51.4% vs 35.6%; odds ratio [OR], 1.85; 95% confidence interval [CI], 1.06-3.25), those on the medical service (67.9% vs 53.1%; OR, 1.86; 95% CI, 1.09-3.16), and those admitted through the emergency department (71.6% vs 51.4%; OR, 2.32; 95% CI, 1.24-4.34). Characteristics associated with increased streamlining included: absence of β-lactam allergy (P<.001), Gram-negative bacteremia (P<.001), admission through the emergency department (P=.001), and admission to a medical service (P=.011). CONCLUSIONS Compared with prior authorization, prospective audit increased antimicrobial streamlining for cases of Gram-negative bacteremia, those admitted through the emergency department, and those admitted to a medical but not surgical service. Infect Control Hosp Epidemiol 2016:1-7.
目的 评估两种抗菌药物管理方法之间抗菌药物优化的可能性。设计 回顾性队列研究。单位 大型学术医疗中心。方法 比较预先授权期和前瞻性审核期内抗菌药物优化的频率和时间。如果有更窄谱的药物可用,优化定义为抗菌药物更换为更窄谱的药物;如果分离株对经验性治疗耐药,则更换为更广谱的药物。纳入的患者年龄≥18岁,患有金黄色葡萄球菌、肠球菌属或任何需氧革兰阴性菌引起的单一微生物菌血症。结果 共有665例菌血症病例符合纳入标准。所有菌血症病例(审核与限制:60.7%对53.2%;P = 0.12)、金黄色葡萄球菌菌血症(73.2%对76.9%;P = 0.671)和肠球菌菌血症(81.6%对71.9%;P = 0.335)在不同时期的优化频率相似。与限制相比,前瞻性审核期内革兰阴性菌血症病例(51.4%对35.6%;比值比[OR],1.85;95%置信区间[CI],1.06 - 3.25)、内科服务患者(67.9%对53.1%;OR,1.86;95%CI,1.09 - 3.16)以及通过急诊科入院的患者(71.6%对51.4%;OR,2.32;95%CI,1.24 - 4.34)的优化频率增加。与优化增加相关的特征包括:无β - 内酰胺类过敏(P < 0.001)、革兰阴性菌血症(P < 0.001)、通过急诊科入院(P = 0.001)以及入住内科服务(P = 0.011)。结论 与预先授权相比,前瞻性审核增加了革兰阴性菌血症病例、通过急诊科入院的患者以及入住内科而非外科服务患者的抗菌药物优化。《感染控制与医院流行病学》2016年:1 - 7。